Transcapillary Permeability and Subendothelial Distribution of Endothelial and Amniotic Fluid Insulin- Like Growth Factor Binding Proteins in the Rat Heart*
- 1 September 1990
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 127 (3) , 1078-1086
- https://doi.org/10.1210/endo-127-3-1078
Abstract
Insulin-like growth factor (IGF) binding proteins (IGFBP) were purified from conditioned media of cultured bovine endothelial cells (ECBP) and from human amniotic fluid (IGFBP-1), and then labeled by radioiodination. 125I-ECBP and 125I-IGFBP-1 were perfused through isolated beating rat hearts for 1 and 5 min, and the hearts fixed and analyzed for 125I-BP content and distribution. One to 4% of the perfused 125I-ECBP and 125I-IGFBP-1 crossed the capillary boundary. The ECBPs predominantly localized as intact 125I-BP in connective tissue elements of the heart with less 125-BP in cardiac muscle. The ratio of 125I-ECBP in connective tissue:muscle (normalized to percent vol of these compartments) was .gtoreq. 10:1. In contrast, the IGFBP-1 had a greater affinity for cardiac muscle with ratios of 125I-IGFBP-1 in connective tissue:muscle of approximately 1:2. When 125I-IGF-I, in the absence of any BPs, was perfused through the hearts approximately 3-5% left the microcirculation and was found in subendothelial tissues. 125I-IGF-I localized primarily to cardiac muscle with a distribution of connective tissue:cardiac muscle of about 1:3. The findings in the isolated perfused heart were confirmed in intact animals. After 125I-IGFBP-1 was injected into anesthestized rats and allowed to circulate for 5 min, substantial radioactivity was associated with the heart. As in the isolated heart, the IGFBP-1 preferentially localized to cardiac muscle with a connective tissue:cardiac muscle ratio of 1:3. We conclude that IGFBPs produced by endothelial cells and the IGFBP-1 contained in amniotic fluid can cross the capillary boundaries of the rat heart, and that the ECBPs preferentially localize in connective tissue elements of the mycoardium, whereas IGFBP-1 predominantly localizes in cardiac muscle.This publication has 24 references indexed in Scilit:
- Processing of Insulin-Like Growth Factors I and II by Capillary and Large Vessel Endothelial Cells*Endocrinology, 1986
- Somatomedin-C/Insulin-Like Growth Factor I-Binding Proteins in Human Amniotic Fluid and in Fetal and Postnatal Blood: Evidence of Immunological Homology*Journal of Clinical Endocrinology & Metabolism, 1985
- Isolation of two forms of basement membrane proteoglycans.Journal of Biological Chemistry, 1985
- Immunoassay of a Somatomedin-Binding Protein from Human Amniotic Fluid: Levels in Fetal, Neonatal, and Adult Sera*Journal of Clinical Endocrinology & Metabolism, 1984
- Isolation and characterization of a somatomedin‐binding protein from mid‐term human amniotic fluidEuropean Journal of Biochemistry, 1984
- Demonstration that a Human Hepatoma Cell Line Produces a Specific Insulin-Like Growth Factor Carrier Protein*Journal of Clinical Endocrinology & Metabolism, 1983
- Stereological measurement of cellular and subcellular hypertrophy and hyperplasia in the papillary muscle of adult ratJournal of Molecular and Cellular Cardiology, 1980
- Enzyme-linked immunoassay (ELISA) for connective tissue componentsAnalytical Biochemistry, 1980
- Further Characterization of Growth Hormone-Dependent Somatomedin-Binding Proteins in Rat Serum and Demonstration of Somatomedin-Binding Proteins Produced by Rat Liver Cells in Culture*Endocrinology, 1979
- Characterization of a Protein in Mid-Term Human Amniotic Fluid which Reacts in the Somatomedin-C Radioreceptor Assay*Journal of Clinical Endocrinology & Metabolism, 1977